Taylor Wealth Management Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $3.53M | Sell |
24,190
-1,866
| -7% | -$272K | 2% | 21 |
|
|
2022
Q1 | $4.26M | Sell |
26,056
-1,077
| -4% | -$176K | 1.72% | 26 |
|
|
2021
Q4 | $4.6M | Sell |
27,133
-696
| -3% | -$118K | 1.62% | 26 |
|
|
2021
Q3 | $5.25M | Sell |
27,829
-711
| -2% | -$134K | 1.87% | 22 |
|
|
2021
Q2 | $4.84M | Sell |
28,540
-1,073
| -4% | -$182K | 1.71% | 26 |
|
|
2021
Q1 | $4.18M | Sell |
29,613
-1,021
| -3% | -$144K | 1.53% | 26 |
|
|
2020
Q4 | $3.98M | Buy |
30,634
+6
| +0% | +$780 | 1.53% | 26 |
|
|
2020
Q3 | $4.46M | Buy |
30,628
+744
| +2% | +$108K | 2.04% | 19 |
|
|
2020
Q2 | $4.43M | Sell |
29,884
-3,836
| -11% | -$568K | 2.25% | 16 |
|
|
2020
Q1 | $3.67M | Buy |
+33,720
| New | +$3.67M | 2.25% | 17 |
|
|
2019
Q1 | – | Sell |
-80
| Closed | -$6K | – | 49 |
|
|
2018
Q4 | $6K | Hold |
80
| – | – | ﹤0.01% | 98 |
|
|
2018
Q3 | $7K | Hold |
80
| – | – | ﹤0.01% | 109 |
|
|
2018
Q2 | $8K | Hold |
80
| – | – | ﹤0.01% | 115 |
|
|
2018
Q1 | $10K | Hold |
80
| – | – | ﹤0.01% | 101 |
|
|
2017
Q4 | $10K | Sell |
80
-50
| -38% | -$6.25K | ﹤0.01% | 127 |
|
|
2017
Q3 | $15K | Hold |
130
| – | – | 0.01% | 121 |
|
|
2017
Q2 | $10K | Hold |
130
| – | – | ﹤0.01% | 133 |
|
|
2017
Q1 | $7K | Hold |
130
| – | – | ﹤0.01% | 139 |
|
|
2016
Q4 | $5K | Hold |
130
| – | – | ﹤0.01% | 144 |
|
|
2016
Q3 | $9K | Sell |
130
-20
| -13% | -$1.39K | ﹤0.01% | 130 |
|
|
2016
Q2 | $8K | Sell |
150
-75
| -33% | -$4K | ﹤0.01% | 122 |
|
|
2016
Q1 | $14K | Sell |
225
-30,980
| -99% | -$1.93M | 0.01% | 107 |
|
|
2015
Q4 | $2.94M | Buy |
31,205
+85
| +0.3% | +$8K | 1.27% | 28 |
|
|
2015
Q3 | $2.5M | Sell |
31,120
-478
| -2% | -$38.4K | 1.21% | 28 |
|
|
2015
Q2 | $3.79M | Sell |
31,598
-3
| -0% | -$360 | 1.21% | 34 |
|
|
2015
Q1 | $3.3M | Buy |
+31,601
| New | +$3.3M | 1.04% | 38 |
|